SXC-2023
UNII 90EHI51QO6

Substance Identification & Data

This profile provides standardized clinical and technical data for Sxc-2023, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 90EHI51QO6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1695562-36-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
90EHI51QO6
CAS Registry Number
1695562-36-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SXC-2023
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C13H15NO4S
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
QHXPWGXGEBJOCG-NSHDSACASA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
SXC-2023
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c1c(ccc(c1)C)C(SC[C@@H](C(O)=O)NC(=O)C)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sxc-2023. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

L-Cysteine, N-acetyl-S-(4-methylbenzoyl)-
N-Acetyl-S-(4-methylbenzoyl)-L-cysteine

Technical Codes

SLC7A11
SXC-2023